Pain Reduction Using NEurostimulation Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 125 participants.

Also called NCT05311956

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 125 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05311956
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05311956. Randomized; quadruple masking; primary purpose treatment. Start 2022-10-24 (actual); primary completion 2026-01-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pain Reduction Using NEurostimulation Study
Acronym
PRUNE
Condition
End Stage Kidney Disease
Condition
Chronic Pain
Intervention (Device)
Active tDCS
Intervention (Device)
Sham tDCS
Lead sponsor
Weill Medical College of Cornell University (class: other)
Collaborator
Metropolitan Jewish Health System (class: other)
Collaborator
Rogosin Institute (class: not stated)
Collaborator
Cornell University (class: other)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05311956
Content hash
6a285ce5c69d631f884ddc53b5691d53a58438f9c3048ff412a72237d6fd903e